Cargando…
In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells
Background: Chemotherapy is one of the antitumor therapies used worldwide in spite of its serious side effects and unsatisfactory results. Many attempts have been made to increase its activity and reduce its toxicity. 5-Fluorouracil (5-FU) is still a widely-used chemotherapeutic agent, especially in...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344244/ https://www.ncbi.nlm.nih.gov/pubmed/28536371 http://dx.doi.org/10.3390/biomedicines4010003 |
_version_ | 1782513499024392192 |
---|---|
author | Al-Shammari, Ahmed M. Salman, Marwa I. Saihood, Yahya D. Yaseen, Nahi Y. Raed, Khansaa Shaker, Hiba Kareem Ahmed, Aesar Khalid, Aseel Duiach, Ahlam |
author_facet | Al-Shammari, Ahmed M. Salman, Marwa I. Saihood, Yahya D. Yaseen, Nahi Y. Raed, Khansaa Shaker, Hiba Kareem Ahmed, Aesar Khalid, Aseel Duiach, Ahlam |
author_sort | Al-Shammari, Ahmed M. |
collection | PubMed |
description | Background: Chemotherapy is one of the antitumor therapies used worldwide in spite of its serious side effects and unsatisfactory results. Many attempts have been made to increase its activity and reduce its toxicity. 5-Fluorouracil (5-FU) is still a widely-used chemotherapeutic agent, especially in combination with other chemotherapies. Combination therapy seems to be the best option for targeting tumor cells by different mechanisms. Virotherapy is a promising agent for fighting cancer because of its safety and selectivity. Newcastle disease virus is safe, and it selectively targets tumor cells. We previously demonstrated that Newcastle disease virus (NDV) could be used to augment other chemotherapeutic agents and reduce their toxicity by halving the administered dose and replacing the eliminated chemotherapeutic agents with the Newcastle disease virus; the same antitumor activity was maintained. Methods: In the current work, we tested this hypothesis on different tumor cell lines. We used the non-virulent LaSota strain of NDV in combination with 5-FU, and we measured the cytotoxicity effect. We evaluated this combination using Chou–Talalay analysis. Results: NDV was synergistic with 5-FU at low doses when used as a combination therapy on different cancer cells, and there were very mild effects on non-cancer cells. Conclusion: The combination of a virulent, non-pathogenic NDV–LaSota strain with a standard chemotherapeutic agent, 5-FU, has a synergistic effect on different tumor cells in vitro, suggesting this combination could be an important new adjuvant therapy for treating cancer. |
format | Online Article Text |
id | pubmed-5344244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-53442442017-05-23 In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells Al-Shammari, Ahmed M. Salman, Marwa I. Saihood, Yahya D. Yaseen, Nahi Y. Raed, Khansaa Shaker, Hiba Kareem Ahmed, Aesar Khalid, Aseel Duiach, Ahlam Biomedicines Article Background: Chemotherapy is one of the antitumor therapies used worldwide in spite of its serious side effects and unsatisfactory results. Many attempts have been made to increase its activity and reduce its toxicity. 5-Fluorouracil (5-FU) is still a widely-used chemotherapeutic agent, especially in combination with other chemotherapies. Combination therapy seems to be the best option for targeting tumor cells by different mechanisms. Virotherapy is a promising agent for fighting cancer because of its safety and selectivity. Newcastle disease virus is safe, and it selectively targets tumor cells. We previously demonstrated that Newcastle disease virus (NDV) could be used to augment other chemotherapeutic agents and reduce their toxicity by halving the administered dose and replacing the eliminated chemotherapeutic agents with the Newcastle disease virus; the same antitumor activity was maintained. Methods: In the current work, we tested this hypothesis on different tumor cell lines. We used the non-virulent LaSota strain of NDV in combination with 5-FU, and we measured the cytotoxicity effect. We evaluated this combination using Chou–Talalay analysis. Results: NDV was synergistic with 5-FU at low doses when used as a combination therapy on different cancer cells, and there were very mild effects on non-cancer cells. Conclusion: The combination of a virulent, non-pathogenic NDV–LaSota strain with a standard chemotherapeutic agent, 5-FU, has a synergistic effect on different tumor cells in vitro, suggesting this combination could be an important new adjuvant therapy for treating cancer. MDPI 2016-01-29 /pmc/articles/PMC5344244/ /pubmed/28536371 http://dx.doi.org/10.3390/biomedicines4010003 Text en © 2015 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Al-Shammari, Ahmed M. Salman, Marwa I. Saihood, Yahya D. Yaseen, Nahi Y. Raed, Khansaa Shaker, Hiba Kareem Ahmed, Aesar Khalid, Aseel Duiach, Ahlam In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells |
title | In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells |
title_full | In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells |
title_fullStr | In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells |
title_full_unstemmed | In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells |
title_short | In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells |
title_sort | in vitro synergistic enhancement of newcastle disease virus to 5-fluorouracil cytotoxicity against tumor cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344244/ https://www.ncbi.nlm.nih.gov/pubmed/28536371 http://dx.doi.org/10.3390/biomedicines4010003 |
work_keys_str_mv | AT alshammariahmedm invitrosynergisticenhancementofnewcastlediseasevirusto5fluorouracilcytotoxicityagainsttumorcells AT salmanmarwai invitrosynergisticenhancementofnewcastlediseasevirusto5fluorouracilcytotoxicityagainsttumorcells AT saihoodyahyad invitrosynergisticenhancementofnewcastlediseasevirusto5fluorouracilcytotoxicityagainsttumorcells AT yaseennahiy invitrosynergisticenhancementofnewcastlediseasevirusto5fluorouracilcytotoxicityagainsttumorcells AT raedkhansaa invitrosynergisticenhancementofnewcastlediseasevirusto5fluorouracilcytotoxicityagainsttumorcells AT shakerhibakareem invitrosynergisticenhancementofnewcastlediseasevirusto5fluorouracilcytotoxicityagainsttumorcells AT ahmedaesar invitrosynergisticenhancementofnewcastlediseasevirusto5fluorouracilcytotoxicityagainsttumorcells AT khalidaseel invitrosynergisticenhancementofnewcastlediseasevirusto5fluorouracilcytotoxicityagainsttumorcells AT duiachahlam invitrosynergisticenhancementofnewcastlediseasevirusto5fluorouracilcytotoxicityagainsttumorcells |